Our September Featured Research Trainee, Arthur Lee, MD, studies untargeted metabolomic profiling to improve the lives of children with chronic kidney disease.
The purpose of this NIH-funded placebo-controlled clinical trial is to determine how well ferric citrate will lower FGF23, correct anemia and iron levels in the blood, and maintain normal levels of phosphate in children with CKD.
Stimulating the generation of new knowledge pertaining to the progression of chronic kidney disease and the development and evolution of associated comorbidities.
